Life Cycle Management: How to Resolve a Competitive Threat Quickly and Reliably *Redacted for public/non-client distribution.

Slides:

Advertisements

Similar presentations

Managing Intellectual Property Assets in International Business Anil Sinha, Counsellor, SMEs Division World Intellectual Property Organization (WIPO)

Advertisements

P ROFESSOR R UTH O KEDIJI First to File Patent Systems How the New U.S. System Compares to other Systems Around the World.

MELISSA ASFAHANI Patent Attorney El Paso, TX

Pharma Workshop IV Patent Linkage in the USA Lawrence T. Welch Eli Lilly and Company.

New Product Launch Clearance How to identify - and quickly resolve - potential impediments to launching a unique new pharmaceutical dosage form *Redacted.

29 April 2011 Brian Cordery Bristows London

Chapter 8.  A civil action relates to an act or omission that infringes the rights of a person, group or government instrumentality and seeks to return.

Hatch-Waxman Reforms Under The “Medicare Prescription Drug, Improvement, And Modernization Act 2003” Brian V. Slater, Esq. Fitzpatrick,

EVALUATION OF DISPUTE RESOLUTION METHODS. Strengths of Mediation  Strengths 1) Mediation is often less expensive. Mediation avoids the costs of a trial,

PRIVILEGE A general overview David Musker, EPA R G C Jenkins, London.

Privilege, Privacy, and Waiver. Privilege Attorney/Client In the law of evidence, a client's privilege to refuse to disclose, and to prevent any other.

July 8, Enhanced Examination Timing Control Robert A. Clarke Deputy Director Office of Patent Legal Administration

Life Cycle Management Case Study: Preventing Generic API *Redacted for public/non-client distribution.

Case Study in Life Cycle Management Supporting Infringement Litigation Against Five Generics With Mission-Critical Patent Prosecution *Redacted for public/non-client.

Registering Your Copyright with the U.S. Copyright Office Insert Date Insert Instructors’ Names / Titles The following slides are based on the work of.

The International Patent System Amendments to the PCT Regulations as from 1 July 2015.

Defensive Publishing: The Key to Gaining and Keeping the Competitive Advantage.

© 2009 Pharmaceutical Law Group PC Market Exclusivity Paradigm Gregory J. Glover, MD, JD Pharmaceutical Law Group

The Importance and Role of Patent Information Jerusalem 21 June 2010 Andrew Czajkowski Head, Innovation and Technology Support Section.

USPTO PCT Task Force Public Hearing January 13, 2010 Lawrence T. Welch Assistant General Patent Counsel Eli Lilly & Co.

A very short introduction to patents & access to medicines.

STRICTLY CONFIDENTIAL Positioning for Growth Tasmanian Strata Industry Tim MacKenzie Associate Director Friday 9 th August.

Notice of Privacy Practices Nebraska SNIP Privacy Subgroup July 18, 2002 Michael J. Brown, MHA, CPA Vice-President, Administrative & Regulatory Affairs,

Copyright “Gotchas” To Avoid When Using Media and Electronic Sources in the Classroom Paul Angerhofer BYU University Counsel.

Keeping It Legal: Finding Images for Your Online Course.

© Kolisch Hartwell 2014 All Rights Reserved, Page 1 Oregon Best Fest September 2014 Peter D. Sabido Intellectual Property Attorney Kolisch Hartwell, P.C.

I DENTIFYING AND P ROTECTING I NTELLECTUAL P ROPERTY Tyson Benson

Overview of IP Protection Mechanisms in the United States Presented by: Daniel Waymel UT Dallas – August 2013.

Main Argument: Software should not be patentable because it discourages progress and innovation in the field. "...There is absolutely no evidence, whatsoever—

The in-house viewpoint on due diligence for IP acquisition, including best practices for messaging results to management Jen Sieczkiewicz, Ph.D., J.D.

Non-Patent Literature (NPL) in the Patent Prior-Art Search USPTO Patents Search Templates, WIPO Requirement & EPO Resources Connie Wu Engineering and Patent.

Intellectual Property. John Ayers February 25, 2005.

2011 Industry Sponsored Research Workshop INTELLECTUAL PROPERTY Michael Jaremchuk Associate Director CVIP Phone: FAX:

Preparing a Provisional Patent Application Hay Yeung Cheung, Ph.D. Myers Wolin, LLC March 16, 2013 Trenton Computer Festival 1.

Technology and Consumer Rights in Copyright By Dr. Michael Seadle Michigan State University Libraries.

Anthony C. Tridico, Ph.D. AIPLA BIOTECHNOLOGY COMMITTEE Pinning Down a Moving Target: Patenting Biotech in Uncertain Times.

EXCLUSIVE MARKETING RIGHTS & MAIL-BOX APPLICATIONS BY Manish Kumar Prusty T. Harish.

Due Diligence Strategy for In-house Counsel Jen Sieczkiewicz, Ph.D., J.D. Research & Business Development Counsel.

Promotion of Innovation: Usefulness and value of Patent Information Andrew Czajkowski Head, Innovation and Technology Support Section Ulaanbaatar March.

Licensing Early-Stage Academic Technologies to the Pharmaceutical Industry: Some Dos and Don’ts to Improve Success Gerald J. Siuta, Ph.D. President Siuta.

Example 8 Medication Chapter 2.3 A nurse has two solutions that contain different concentrations of a certain medication. One is a 12% concentration, and.

PATENT POOL & its CONCERNS PATENT POOL & its CONCERNS Manmohan A Amonkar 20 July 2010.

Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.

Legal Requirements for School Bonds C.A.S.H. Local Workshop Planning for 2016 Local Bond Success September 22, 2015 and September 29, 2015 Presented by:

Nadya Reingand, PhD Washington DC, USA © Copyright. All rights reserved. Патентование в США Patent Hatchery LLC

Casting Call: Roles of the Board and Staff in Charter School Authorizing CARSNet San Diego, CA October 1, 2015 Presented by: David Patterson, Ed. D. Faris.

Copyright and Intellectual Property Right 1. 2 Use and Protection of Intellectual Property in Online Business Intellectual property (general term) includes:

Copyrights Questions and Answers. What Is a Copyright? A copyright protects someone who creates an original work. An original work can be a book, a play,

Nadya Reingand, Washington DC, USA From Science to Business © Copyright. All rights reserved.

Ethical and Legal Technology Use By: Ashley Zickefoose.

© 2011 Dannis Woliver Kelley This training is provided for educational, compliance and loss-prevention purposes only and, absent the express, prior agreement.

1 US and Japan Sides Discussion and Update: Attorney-Client Privilege Takahiro FUJIOKA Meisei International Patent Firm AIPLA 2004 Mid-Winter Institute.

1 Lightening intro to intellectual property law – Sept. 26, 2002 Based in part on original notes by Randy Davis.

Basse Asplund, M Sc, Ph D Patent Attorney and Partner Stockholm, Uppsala, Göteborg och Lund.

ImmoProtect An Introduction to. Potential problems during a transaction Hidden defects Passation of title Conflict with a neighbour or tenant Obligations.

Recent FTC Pharmaceutical Cases: Background and Examples Sue H. Kim This presentation was prepared from public sources. The views expressed herein do not.

PTAB Litigation 2016 Part 11 – Bio/Pharma Issues 1.

Patent Applications Just the Frequently Asked Questions.

Legal issues for the Entrepreneur. Intellectual property Any patents,trademarks, copy rights or trade secrets held by the entrepreneur. Lack of understanding.

Software piracy and software patents

Story scenes & Learning points Introduction #1. A doubtful answer

This presentation uses a free template provided by FPPT.com Business Environment Dr. Aravind Banakar –

This presentation uses a free template provided by FPPT.com Business Environment

This presentation uses a free template provided by FPPT.com Business Environment

Finding and Understanding Patents

Chapter 4: Patents and Trade Secrets in the Information Age.

Jackie Hutter, MS, JD What Innovators Need to Know about IP Protection: A Business-Focused Approach Jackie Hutter, MS, JD

Copyrights Questions And Answers.

Presentation transcript:

Life Cycle Management: How to Resolve a Competitive Threat Quickly and Reliably *Redacted for public/non-client distribution

Casodex(R) bicalutamide is a leading prostate cancer treatment. Faced with patent expiration, an API maker developed a way to make more pure API, less expensively.

Filed US patent on 08 March 2007 (Serial No. 11/574,886 Examination projected to begin ca. 08 March 2010 Pre-exam review of published US applications had surprising revelation:

Apotex had filed a US patent on the same thing Apotex's U.S. application was filed 26 July 2006 – a year earlier than ours. By 11 Jan 2008, the USPTO had approved 14 of Apotex's 21 patent claims

Options Concede infringement of Apotex's patent and withdraw our own API? Correct the coverage of our patent to literally claim Apotex's product? “Possession is 9/10ths of the law,” however; such correction would be difficult to do after Apotex obtains its own patent Request interference? Both answers are wrong. A successful request would provoke an expensive and slow legal fight; no request would cede the market to Apotex.

For a difficult situation, an innovative solution...

Difficult situations demand innovative solutions. We thus engineered a way to: Block Apotex's patent entirely, even though it was on the verge of issuing; and Avoid the delay and expense of an interference proceeding. Apotex thus abandoned their patent entirely, and withheld their product from the market.

For further information: Pharmaceutical Patent Attorneys, LLC Morristown, New Jersey USA www. LicensingLaw. Net For further study: How to Control the U.S. Pharmaceutical API Market..., Journal of Intel. Prop. Rights, vol. 13, pp (2008) Orange Book Patent Listing..., Journal of Generic Medicines vol. 1, pp (2004)

© 2010 Pharmaceutical Patent Attorneys, LLC Morristown, New Jersey For further information on how this approach can be applied to protect your API, contact: +1 (973) This presentation does not constitute legal advice and does not form an attorney-client relationship between the copyright holder and the viewer. Certain information has been redacted from this presentation to make it suitable for distribution to the public. Clients may obtain an unredacted copy on request.